Search Results

Filter
  • 1-10 of  22,794 results for ""MEXILETINE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Severe caffeine poisoning with mexiletine successfully treated by extracorporeal methods.

  • Authors : Kohara S; Department of Clinical Toxicology, Saitama Medical University, Japan; Department of Critical Care Medicine and Trauma, National Hospital Organization Disaster Medical Center, Japan. Electronic address: .

Subjects: Mexiletine*/Mexiletine*/Mexiletine*/poisoning ; Mexiletine*/Mexiletine*/Mexiletine*/therapeutic use ; Caffeine*/Caffeine*/Caffeine*/poisoning

  • Source: The American journal of emergency medicine [Am J Emerg Med] 2024 Dec; Vol. 86, pp. 190.e5-190.e7. Date of Electronic Publication: 2024 Sep 26.Publisher: W B Saunders Country of Publication: United States NLM ID: 8309942 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Recommendations of an expert group for the cardiac assessment of non-dystrophic myotonia adult patients treated with mexiletine.

  • Authors : Vicart S; Muscle Channelopathies Reference Center, Department of Neuro-Myology, Assistance Publique-Hôpitaux de Paris, University Hospital Pitié-Salpêtrière, Sorbonne Université, INSERM UMR 974, Institute of Myology, 47-83 Bd de l'Hôpital, 75013 Paris, France. Electronic address: .; Wahbi K

Subjects: Mexiletine*/Mexiletine*/Mexiletine*/therapeutic use ; Mexiletine*/Mexiletine*/Mexiletine*/pharmacology ; Myotonia*/Myotonia*/Myotonia*/drug therapyNondystrophic myotonia

  • Source: Neuromuscular disorders : NMD [Neuromuscul Disord] 2024 Nov; Vol. 44, pp. 104464. Date of Electronic Publication: 2024 Sep 25.Publisher: Pergamon Press Country of Publication: England NLM ID: 9111470 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial.

  • Authors : Vivekanandam V; Centre for Neuromuscular Disorders, The National Hospital for Neurology and Neurosurgery, London, UK; Queen Square Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK. Electronic address: .

Subjects: Lamotrigine*/Lamotrigine*/Lamotrigine*/therapeutic use ; Mexiletine*/Mexiletine*/Mexiletine*/therapeutic use ; Mexiletine*/Mexiletine*/Mexiletine*/pharmacology Nondystrophic myotonia

  • Source: The Lancet. Neurology [Lancet Neurol] 2024 Oct; Vol. 23 (10), pp. 1004-1012.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465

Record details

×
Academic Journal

Effects of SZV-2649, a new multiple ion channel inhibitor mexiletine analogue.

  • Authors : Mohammed ASA; Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.; Naveed M

Subjects: Anti-Arrhythmia Agents*/Anti-Arrhythmia Agents*/Anti-Arrhythmia Agents*/pharmacology ; Anti-Arrhythmia Agents*/Anti-Arrhythmia Agents*/Anti-Arrhythmia Agents*/chemistry ; Mexiletine*/Mexiletine*/Mexiletine*/pharmacology

  • Source: Scientific reports [Sci Rep] 2024 Oct 05; Vol. 14 (1), pp. 23188. Date of Electronic Publication: 2024 Oct 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness and safety of mexiletine versus placebo in patients with myotonia: a systematic review and meta-analysis.

  • Authors : Elettreby AM; Faculty of Medicine, Mansoura University, El Gomhouria St, Mansoura, 35511, Egypt. .; Medical Research Group of Egypt, Negida Academy LLC, Arlington, MA, 02474, USA. .

Subjects: Mexiletine*/Mexiletine*/Mexiletine*/therapeutic use ; Myotonia*/Myotonia*/Myotonia*/drug therapy; Humans

  • Source: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Aug; Vol. 45 (8), pp. 3989-4001. Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.

  • Authors : Crotti L; Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Istituto Auxologico Italiano, IRCCS, Milan, Italy (L.C., F.D., G.M., F.G., P.C., F.L.F.G., M.T., L.S., P.J.S.).; Departments of Medicine and Surgery (L.C.), University of Milano-Bicocca, Milan, Italy.

Subjects: Mexiletine*/Mexiletine*/Mexiletine*/pharmacology ; Mexiletine*/Mexiletine*/Mexiletine*/therapeutic use ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/drug effects Long Qt Syndrome 2

  • Source: Circulation [Circulation] 2024 Aug 13; Vol. 150 (7), pp. 531-543. Date of Electronic Publication: 2024 Jun 28.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Development, validation and long-term evaluation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of amiodarone, desethylamiodarone and mexiletine in human plasma and serum.

  • Authors : Braakhuis MWA; Department of Pharmacy and Clinical Pharmacology, University of Amsterdam, Amsterdam UMC Location AMC, Amsterdam, The Netherlands; Medicines for Society Platform, Amsterdam UMC - University of Amsterdam, Amsterdam, The Netherlands. Electronic address: .

Subjects: Amiodarone*/Amiodarone*/Amiodarone*/blood ; Amiodarone*/Amiodarone*/Amiodarone*/analogs & derivatives ; Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/methods

  • Source: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2024 Aug 01; Vol. 1243, pp. 124233. Date of Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Expert opinion on mexiletine treatment in adult patients with myotonic dystrophy.

  • Authors : Wahbi K; Centre de Référence des Maladies Neuromusculaires Nord/Est/Île-de-France, Cardiology Department, Cochin Hospital, AP-HP, Paris Cité University, 75014 Paris, France; Paris Cardiovascular Research Centre (PARCC), Inserm Unit 970, Georges-Pompidou European Hospital, 75015 Paris, France. Electronic address: .

Subjects: Mexiletine*/Mexiletine*/Mexiletine*/therapeutic use ; Mexiletine*/Mexiletine*/Mexiletine*/adverse effects ; Myotonic Dystrophy*/Myotonic Dystrophy*/Myotonic Dystrophy*/drug therapy

  • Source: Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2024 Jun-Jul; Vol. 117 (6-7), pp. 450-456. Date of Electronic Publication: 2024 Apr 15.Publisher: Elsevier Masson Country of Publication: Netherlands NLM ID: 101465655 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias.

  • Authors : Alhourani N; Department of Cardiology II: Electrophysiology, University Hospital Münster, Münster, Germany. .; Wolfes J

Subjects: Mexiletine*/Mexiletine*/Mexiletine*/therapeutic use ; Anti-Arrhythmia Agents*/Anti-Arrhythmia Agents*/Anti-Arrhythmia Agents*/therapeutic use; Humans

  • Source: Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2024 Jun; Vol. 113 (6), pp. 791-800. Date of Electronic Publication: 2024 Feb Publisher: Country of Publication: Germany NLM ID: 101264123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1861-0692

Record details

×
Academic Journal

hERG stereoselective modulation by mexiletine-derived ureas: Molecular docking study, synthesis, and biological evaluation.

  • Authors : Milani G; Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Bari, Italy.; Budriesi R

Subjects: Mexiletine*/Mexiletine*/Mexiletine*/pharmacology ; Long QT Syndrome*/Long QT Syndrome*/Long QT Syndrome*/genetics ; Long QT Syndrome*/Long QT Syndrome*/Long QT Syndrome*/therapy

  • Source: Archiv der Pharmazie [Arch Pharm (Weinheim)] 2023 Oct; Vol. 356 (10), pp. e2300116. Date of Electronic Publication: 2023 Jul 17.Publisher: Wiley-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 0330167 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  22,794 results for ""MEXILETINE""